A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.

Autor: López-Sendón Moreno JL; Neurology Department, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034, Madrid, Spain. joselopezsendon@hotmail.com.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. joselopezsendon@hotmail.com.; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. joselopezsendon@hotmail.com., García Caldentey J; Neurology Department, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034, Madrid, Spain., Trigo Cubillo P; Neurology Department, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034, Madrid, Spain., Ruiz Romero C; Neurobiology Department, Hospital Ramón y Cajal, Madrid, Spain., García Ribas G; Neurology Department, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034, Madrid, Spain., Alonso Arias MA; Neurology Department, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034, Madrid, Spain., García de Yébenes MJ; Instituto de Salud Músculoesquelética, Madrid, Spain., Tolón RM; Fundación Hospital de Alcorcón, Madrid, Spain., Galve-Roperh I; Department of Biochemistry and Molecular Biology I, Faculty of Biology, Complutense University, Madrid, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Sagredo O; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Department of Biochemistry and Molecular Biology III, Faculty of Medicine, Complutense University, Madrid, Spain., Valdeolivas S; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Department of Biochemistry and Molecular Biology III, Faculty of Medicine, Complutense University, Madrid, Spain., Resel E; Department of Biochemistry and Molecular Biology I, Faculty of Biology, Complutense University, Madrid, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Ortega-Gutierrez S; Department of Organic Chemistry I, Faculty of Chemistry, Complutense University, Madrid, Spain., García-Bermejo ML; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Fernández Ruiz J; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Department of Biochemistry and Molecular Biology III, Faculty of Medicine, Complutense University, Madrid, Spain., Guzmán M; Department of Biochemistry and Molecular Biology I, Faculty of Biology, Complutense University, Madrid, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., García de Yébenes Prous J; Neurology Department, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034, Madrid, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.

Publikováno v: Journal of neurology [J Neurol] 2016 Jul; Vol. 263 (7), pp. 1390-400. Date of Electronic Publication: 2016 May 09.

[Laryngeal dystonia. Comparison of transcutaneous and transoral injection of botulinum toxin]

Autor: Pj, García Ruiz, Cenjor Español C, Rosario Sanchez-Pernaute, Astarloa R, Sánchez Bernardos V, García de Yébenes Prous J

Publikováno v: Europe PubMed Central

Spasmodic dysphonia is a focal dystonia that effects the proximal muscles (adduction dystonia) or dilatory (abduction dystonia) of the larynx. Botulinum toxin (BTX), generally delivered by percutaneous injection, is the treatment of choice. Recently,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a7d291dbb83342f2951a149b0671a0da
http://europepmc.org/abstract/med/8768677

Effect of nicardipine on essential tremor: brief report.

Autor: García Ruiz PJ; Department of Neurology, Fundación Jimenez Diaz, Madrid, Spain., García de Yébenes Prous J, Jimenez Jimenez J

Publikováno v: Clinical neuropharmacology [Clin Neuropharmacol] 1993 Oct; Vol. 16 (5), pp. 456-9.

TIBBİ KENEVİR VE SAĞLIK: FARMAKOLOJİK BİR DERLEME. (Turkish)

Autor: BALPINAR, Özge, AYTAÇ, Selim

Publikováno v: Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi; 2021, Vol. 45 Issue 3, p631-651, 21p

Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington’s Disease Patients.

Autor: Szejko, Natalia, Picón, Carmen, García-Caldentey, Juan, Garcia de Yebenes, Justo, Carlos Alvarez-Cermeño, Jose, Maria Villar, Luisa, López-Sendón Moreno, José Luis

Publikováno v: PLoS Currents; 2018, p1-11, 11p, 1 Chart, 2 Graphs